Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NQO2 | P16083 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8169571 | 0.80 | CA14 (0.35) | CA14TDP1CA12CA1CA7 | |
| SCHEMBL28323963 | 0.79 | TDP1 (0.51) | CA14TDP1MEN1GAAKMT2A | |
| SCHEMBL29850083 | 0.78 | TDP1 (0.38) | CA14TDP1MEN1GAAKMT2A | |
| SCHEMBL991812 | 0.78 | CA14 (0.38) | CA14TDP1MEN1GAAKMT2A | |
| SCHEMBL9426075 | 0.77 | CA1 (0.35) | CA14TDP1MEN1GAAKMT2A | |
| SCHEMBL21664460 | 0.77 | CA14 (0.35) | CA14TDP1CA12CA1CA7 | |
| SCHEMBL8670353 | 0.77 | CA14 (0.35) | CA14TDP1CA12CA1CA7 | |
| SCHEMBL30981829 | 0.76 | TDP1 (0.43) | CA14TDP1MEN1GAAKMT2A | |
| SCHEMBL1867766 | 0.75 | CA14 (0.35) | CA14TDP1MEN1GAAKMT2A | |
| SCHEMBL8884501 | 0.75 | CA1 (0.33) | CA14TDP1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109569331-B | Preparation method of hydrophilic antibacterial filter membrane | 万华化学集团股份有限公司 | 2021-10-22 | — | — | CN | disclosed |